Externally applied medicine liquid and medicine powder for treating recurrent aphtha

A technology for recurrent aphthous ulcers and liquid medicine, which is applied in the field of external use and western medicine combined preparations, can solve the problems of affecting the patient's speech and eating, the patient has a foreign body sensation, and the pain relief effect is poor, and achieves convenient clinical application, simple preparation method and effect. significant effect

Inactive Publication Date: 2007-08-22
王风云 +4
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there are medicine films for the treatment of recurrent aphthous ulcers, which not only affect the patient's speech and eating, but also cause the patient's discomfort due to the foreign body sensation, and the pain relief effect is poor
There are also traditional Chinese medicine powders that are taken locally, but because there is no removal and local cleaning of the necrotic and exfoliated mucosal cells on the ulcer surface, the contact and absorption of the medicine with the ulcer surface is affected, resulting in poor efficacy, and the patient does not heal after multiple medications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0033] An externally used liquid medicine for treating recurrent aphthous ulcers, the raw materials are 0.1 parts by weight of borneol and 100 parts by weight of sterile distilled water.

[0034] An external medicinal powder for treating recurrent aphthous ulcers used in conjunction with the liquid medicine, the raw materials for making the active ingredients of the powder are as follows in parts by weight: compound sulfamethoxazole 5, metronidazole 5, dexamethasone 2, vitamin C 5. Borneol 0.5.

[0035] When preparing the medicinal solution, grind the borneol into fine powder, and add it into distilled water according to the required parts by weight to prepare the required medicinal solution.

[0036] When preparing the medicinal powder, the raw materials of the medicinal powder are all crushed according to the required parts by weight and passed through a 200-mesh sieve to be processed into a fine powder for use.

example 2

[0038] An externally used liquid medicine for treating recurrent aphthous ulcers, the raw materials are composed of 1.0 parts by weight of borneol and 100 parts by weight of sterile distilled water.

[0039] An external medicinal powder for treating recurrent aphthous ulcers used in conjunction with the liquid medicine, the raw materials for making the active ingredients of the powder are as follows in parts by weight: compound sulfamethoxazole 20, metronidazole 30, dexamethasone 12, vitamin C 40. Borneol5.

[0040] The preparation method is the same as above.

example 3

[0042] An externally used liquid medicine for treating recurrent aphthous ulcers, the raw materials are composed of 0.5 parts by weight of borneol and 100 parts by weight of sterile distilled water.

[0043] An external medicinal powder for treating recurrent aphthous ulcers used in conjunction with the above liquid medicine, the raw materials for making the active ingredients of the powder are as follows in parts by weight: compound sulfamethoxazole 10, metronidazole 15, dexamethasone 8, vitamin C 20. Borneol3.

[0044] The preparation method is the same as above.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The present invention is externally applied medicine liquid and medicine powder for treating recurrent aphtha. The medicine liquid consists of borneol 0.1-1.0 weight portions and abaterial distilled water 100 weight portions; and the medicine powder consists of compound sulfamethoxazole 5-20 weight portions, metronidazole 5-30 weight portions, dexamethasone 2-12 weight portions, vitamin C 5-40 weight portions, and borneol 0.5-5 weight portions. The medicine liquid and the medicine powder are applied to the affected parts for treating recurrent aphtha.

Description

technical field [0001] The invention relates to an externally-used combined preparation of Chinese medicine and western medicine, in particular to an externally-used liquid medicine and medicine powder for treating recurrent aphthous ulcers. Background technique [0002] Recurrent oral ulcer is commonly called as recurrent oral ulcer, is a kind of modal oral mucosa ulcer property damage with recurrent feature. The etiology and pathogenesis of this disease are still unclear. There are many clinically observed pathogenesis factors, such as indigestion, constipation, intestinal parasites, lack of sleep, fatigue, cold, mental stimulation, female menstrual period or menopause, etc. In recent years, some scholars believe that the disease is an autoimmune disease. [0003] The clinical features of this disease are often natural onset, protracted course, and genetic predisposition. It is specifically manifested in the non-keratinized or low-keratinized parts of the oral mucosa, s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/045A61K31/573A61P1/02A61K31/375A61K31/4164A61K31/635
Inventor 王风云宋敏袁茹茹刘培菊潘光惠
Owner 王风云
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products